Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion
Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been [...]
Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been [...]
A baffling overdose death took investigators to the frontier of [...]
Half a year after being spurned by the FDA and [...]
Ambrosia Biosciences is aiming to move the market beyond peptide-based [...]
Eli Lilly has gone big in the name of neuroscience, [...]
The company is looking to work out an arrangement with [...]
Deflated balloons? Pricier sugar? The fighting in the Middle East [...]
With a second phase 3 win for Tyvaso in idiopathic [...]
Astellas Pharma has become the latest company to pull back [...]
One of the world’s leading investment firms has broken its [...]